Eli Lilly, Novo Nordisk and Zepbound
Digest more
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, predicted that though Trump had spared the industry with tariffs, that wouldn't last much longer.
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves. Qatar pushes back on reports of $400M Boeing jet gift to Trump
The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult diseases.
The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the workforce-talent pipeline.
Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation and workforce development.
Explore more
Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy to help.”
Eli Lilly and Company (NYSE: LLY) shares are trading lower Tuesday. The stock appears to be moving in reaction to an executive order from the Trump administration aimed at boosting domestic drug manufacturing.
The new research and development site will combine research, process development and clinical trial manufacturing capabilities into one plant.
4don MSN
The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the two sides said.
21hon MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved drugs, analysts say.